Saroja Pharma Industries India Ltd
SAROJASaroja Pharma Industries India Ltd
SAROJA![](https://assets.tickertape.in/sector-icons/health_care.png)
Health CarePharmaceuticals
![](https://assets.tickertape.in/sector-icons/smallcap.png)
SmallcapWith a market cap of ₹17 cr, stock is ranked 4,001
![](https://assets.tickertape.in/sector-icons/high_risk.png)
High RiskStock is 4.99x as volatile as Nifty
42.900.23% (-0.10)
42.900.23% (-0.10)
Price Chart
High
—
Low
—
Returns
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
How to use scorecard? Learn more
Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
— | 3.40 | — |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
43.04 | 6.19 | 0.55% |
Forecast & Ratings
Detailed Forecast—
Forecast data is currently unavailable for this stockPrice
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Saroja Pharma Industries India is actively involved in trading pharmaceutical active pharmaceutical ingredients (API), pharma intermediates, and chemicals used in human and veterinary medicines, including specialty chemical imports and exports.
Peers
Compare with peersSun Pharmaceutical Industries Ltd
PE Ratio
38.18
1Y Return
47.58%
Buy Reco %
68.57
Cipla Ltd
PE Ratio
29.17
1Y Return
48.60%
Buy Reco %
74.19
Zydus Lifesciences Ltd
PE Ratio
28.02
1Y Return
85.79%
Buy Reco %
46.43
Dr Reddy's Laboratories Ltd
PE Ratio
19.02
1Y Return
24.95%
Buy Reco %
40.74
Torrent Pharmaceuticals Ltd
PE Ratio
57.61
1Y Return
49.12%
Buy Reco %
85.71
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Revenue Forecast
Earnings Per Share Forecast
Income
Balance Sheet
Cash Flow
Annual Normal View
Income Statement
Annual Normal View
Financial Year | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | |||||
---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 36.75 | 55.95 | 50.35 | 40.86 | — | |||||
Raw Materials | 33.73 | 50.13 | 48.70 | 38.12 | — | |||||
Power & Fuel Cost | 0.00 | 0.01 | 0.03 | |||||||
Employee Cost | 0.55 | 0.73 | 0.83 | |||||||
Selling & Administrative Expenses | 1.44 | 2.39 | 1.16 | |||||||
Operating & Other expenses | -0.36 | 0.27 | -3.24 | |||||||
EBITDA | 1.39 | 2.42 | 2.87 | 2.74 | — | |||||
Depreciation/Amortization | 0.02 | 0.05 | 0.07 | 0.09 | — | |||||
PBIT | 1.37 | 2.37 | 2.80 | 2.65 | — | |||||
Interest & Other Items | 0.33 | 0.80 | 1.32 | 1.45 | — | |||||
PBT | 1.04 | 1.57 | 1.48 | 1.20 | — | |||||
Taxes & Other Items | 0.30 | 0.44 | 0.43 | 0.33 | — | |||||
Net Income | 0.74 | 1.13 | 1.05 | 0.87 | — | |||||
EPS | 740.00 | 95.83 | 6.64 | 2.49 | — | |||||
DPS | 0.00 | 0.00 | 0.00 | 0.00 | — | |||||
Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | — |
Company Updates
Peers & Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
Saroja Pharma Industries India Ltd | 19.87 | 3.40 | — |
Sun Pharmaceutical Industries Ltd | 38.18 | 6.16 | 0.89% |
Cipla Ltd | 29.17 | 5.07 | 0.87% |
Zydus Lifesciences Ltd | 28.02 | 5.49 | 0.28% |
Price Comparison
Compare SAROJA with any stock or ETFCompare SAROJA with any stock or ETF
SAROJA
Shareholdings
Promoter Holdings Trend
Institutional Holdings Trend
No institutional holdings trend are available
Shareholding Pattern
Sep 2023
Mar 2024
Shareholding History
Foreign Institutions
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
SAROJA has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
Dividends
News & Opinions
Articles & Videos
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant